We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Community Health (CYH) Hits 52-Week High on Solid Q4 Results
Read MoreHide Full Article
Shares of Community Health Systems, Inc. (CYH - Free Report) scaled a fresh 52-week high of $7.47 on Feb 21, before closing the day at $7.18. The company’s impressive fourth-quarter 2019 earnings performance and its strategic initiatives contributed to this rally.
The Zacks Rank #2 (Buy) stock has gained 48.7% in the past year compared with its industry’s 4.5% growth.
Let’s delve deeper to analyze the factors responsible for this upsurge.
What's Driving This Outperformance?
For the fourth quarter, Community Health reported adjusted income of 40 cents per share. However, the Zacks Consensus Estimate was of a loss of 48 cents per share. The bottom line also came in against the year-ago quarter’s loss of 42 cents per share. Also, the company came up with net operating revenues of $3.2 billion, surpassing the Zacks Consensus Estimate by 2.4%.
After witnessing weak performances over the last few quarters, the company bounced back in the fourth quarter of 2019, courtesy of lower operating expenses. The debt also decreased sequentially, which remains impressive to investors. On a same-store basis, the company’s admissions and adjusted admissions inched up in the period. The company delivered total adjusted EBITDA of $447 million, up 6.7% year over year.
The company closed the divestment of three hospitals on Jan 1, 2020. Given these sell-off, the company expects its same-store metrics and cash flow to improve. The sale of units is also going to improve its leverage ratios.
The company’s restructuring initiatives has reduced its costs to a great extent. In 2018 and 2019, its operating costs and expenses declined 19.1% and 9.9% year over year, respectively. The company’s expenses are expected to improve further on the back of its planned business rejig.
Despite several downsides, such as declining revenues and a weak 2020 guidance, we are hopeful that the company will win back its momentum owing to its solid fundamentals like portfolio rationalization.
Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +24.7% per year.
These 7 were selected because of their superior potential for immediate breakout.
Image: Bigstock
Community Health (CYH) Hits 52-Week High on Solid Q4 Results
Shares of Community Health Systems, Inc. (CYH - Free Report) scaled a fresh 52-week high of $7.47 on Feb 21, before closing the day at $7.18. The company’s impressive fourth-quarter 2019 earnings performance and its strategic initiatives contributed to this rally.
The Zacks Rank #2 (Buy) stock has gained 48.7% in the past year compared with its industry’s 4.5% growth.
Let’s delve deeper to analyze the factors responsible for this upsurge.
What's Driving This Outperformance?
For the fourth quarter, Community Health reported adjusted income of 40 cents per share. However, the Zacks Consensus Estimate was of a loss of 48 cents per share. The bottom line also came in against the year-ago quarter’s loss of 42 cents per share. Also, the company came up with net operating revenues of $3.2 billion, surpassing the Zacks Consensus Estimate by 2.4%.
After witnessing weak performances over the last few quarters, the company bounced back in the fourth quarter of 2019, courtesy of lower operating expenses. The debt also decreased sequentially, which remains impressive to investors. On a same-store basis, the company’s admissions and adjusted admissions inched up in the period. The company delivered total adjusted EBITDA of $447 million, up 6.7% year over year.
The company closed the divestment of three hospitals on Jan 1, 2020. Given these sell-off, the company expects its same-store metrics and cash flow to improve. The sale of units is also going to improve its leverage ratios.
The company’s restructuring initiatives has reduced its costs to a great extent. In 2018 and 2019, its operating costs and expenses declined 19.1% and 9.9% year over year, respectively. The company’s expenses are expected to improve further on the back of its planned business rejig.
Despite several downsides, such as declining revenues and a weak 2020 guidance, we are hopeful that the company will win back its momentum owing to its solid fundamentals like portfolio rationalization.
Other Stocks to Consider
Investors interested in the medical sector might take a look at some other top-ranked stocks, namely HCA Healthcare, Inc. (HCA - Free Report) , MEDNAX, Inc. (MD - Free Report) and Select Medical Holdings Corporation (SEM - Free Report) , each of which surpassed estimates in the last reported quarter by 0.98%, 1.11%, 55%, respectively. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Just Released: Zacks’ 7 Best Stocks for Today
Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +24.7% per year.
These 7 were selected because of their superior potential for immediate breakout.
See these time-sensitive tickers now >>